자유게시판 글답변
본문 바로가기
회원가입
로그인
검색보다 편한
즐겨찾기 추가하기
사이트 내 전체검색
검색어
필수
메인메뉴
병원소개
인사말
의료진 소개
케임씨잉 정보
케임씨잉 소식
첨단장비 소개
기타장비 소개
증명원
제휴업체
행복나눔
아프리카 의료봉사
수술클리닉
웨이브 프론트
크리스탈 Plus 라식
프리미엄 라섹
NEW 아마리스 750s
라식 / 라섹
백내장 / 노안교정술
초고도근시 교정술
눈종합검사
수술전후주의사항
원데이라식
특수콘텍트클리닉
하드렌즈
소프트렌즈
드림렌즈(OK렌즈)
CRT 드림렌즈
망막클리닉
황반변성
당뇨망막병증
비문증
망막박리
중심성 망막혈관폐쇠증
망막혈관폐쇠증
포도막염
OPTOS DAYTONA
소아클리닉
소아시력교정
소아약시
소아사시
안질환클리닉
안구건조증
녹내장
결막염
익상편 / 결막점
VDT증후군
원추각막
눈물관 클리닉
수술체험기
가상수술체험
수술체험기
수술후기
예약/상담
온라인상담
온라인 예약
자주 묻는 질문
설문조사
유성케임씨잉안과의원을 오실때 교통수단 무엇을 이용하세요?
자가차량
버스
택시
도보
자유게시판 글답변
이름
필수
비밀번호
필수
이메일
홈페이지
분류
필수
선택하세요
정보
이야기
칭찬
불만
제목
필수
내용
필수
웹에디터 시작
> > > <strong>Exploring New Applications of Antabuse (Disulfiram) in Treating Alcohol Dependency and Beyond</strong> Antabuse, the trade name for disulfiram, has been a cornerstone in the treatment of alcohol dependency since its approval by the FDA in 1951. Over the years, its use has been primarily focused on creating a physical aversion to alcohol, but recent studies have begun to uncover a broader spectrum of potential therapeutic applications. This report delves into the latest research and findings on Antabuse, highlighting its efficacy, potential new uses, <a href="http://xn--vv4bi6jvuj.kr/bbs/board.php?bo_table=free&wr_id=298596">xn--vv4bi6jvuj.kr</a> and the implications for <a href="https://alhajaztravels.com/bog/affordable-umrah-family-packages-2024/">alhajaztravels.com</a> treatment protocols.<br/><br/>Disulfiram works by inhibiting the enzyme acetaldehyde dehydrogenase, causing an unpleasant reaction when alcohol is consumed that includes symptoms such as flushing, nausea, and palpitations. This aversive therapy discourages alcohol consumption and aids in the treatment of chronic alcoholism. The conventional dosage varies from 250 to 500 mg daily, depending on the patient's response and tolerance to the medication.<br/><br/>Researchers have been exploring additional pharmacological targets and mechanisms of disulfiram in the past decade. Notably, a 2019 study by O’Brien and colleagues published in "Clinical Pharmacology & Therapeutics" shed light on its potential anti-cancer properties. The study demonstrated that disulfiram could inhibit NF-κB, a protein complex that plays a crucial role in cellular survival, proliferation, and the development of cancer cells.<br/><br/>This inhibition presents a promising route for the adjunct treatment of certain types of cancer, including liver and breast cancer. Another intriguing area of study is the use of disulfiram in treating cocaine addiction. Cocaine and alcohol share similar <a href="https://search.usa.gov/search?affiliate=usagov&query=metabolic">metabolic</a> pathways, and disulfiram’s mechanism can amplify the adverse effects of cocaine use, thus potentially aiding in discouragement of its consumption. A study conducted by Brewer in 2021 highlighted significant reductions in cocaine use among patients prescribed disulfiram compared to those on alternative treatments or placebos.<br/><br/>Moreover, recent research has also hinted at disulfiram's ability to cross the blood-brain barrier, suggesting its potential role in treating neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases. A preliminary study in 2022 outlined how disulfiram could mitigate neurodegeneration by affecting metal homeostasis and reducing oxidative stress within the brain, pointing towards a multifaceted mechanism that could redefine treatment approaches for these pervasive conditions.<br/><br/>However, the broader application of disulfiram comes with challenges, primarily relating to its side effects, which can include hepatic toxicity, neurological impairments, and severe dermatological reactions. Thus, ongoing research is crucial to balance efficacy with safety, aiming to mitigate these risks while harnessing the full therapeutic potential of the drug. Additionally, there are challenges in patient compliance with disulfiram therapy, partic > >
웹 에디터 끝
자동등록방지
자동등록방지
숫자음성듣기
새로고침
자동등록방지 숫자를 순서대로 입력하세요.
취소
회사소개
개인정보취급방침
서비스이용약관
모바일 버전으로 보기
상단으로
대전광역시 유성구 계룡로 105
(구. 봉명동 551-10번지) 3, 4층 | 대표자 :
김형근, 김기형 |
사업자 등록증 :
314-25-71130
대표전화 :
1588.7655
| 팩스번호 :
042.826.0758
Copyright ©
CAMESEEING.COM
All rights reserved.
접속자집계
오늘
3,256
어제
10,587
최대
16,322
전체
6,157,017
-->